Both in Surgical Instruments
Beyond Air vs Vivos Therapeutics
Over the past year XAIR returned −94.2% and VVOS returned −95.2%; their daily moves had a correlation of 0.00.
XAIR −94.2% VVOS −95.2%Growth of $1, one year, split-adjusted
| Metric | XAIR | VVOS |
|---|---|---|
| Price | $2.83 | $0.1505 |
| Market cap | $2.8M | $3.0M |
| Today | +9.27% | +12.23% |
| 1 month | −36.8% | −33.1% |
| 6 months | −79.0% | −86.2% |
| Year to date | −80.5% | −92.6% |
| 1 year | −94.2% | −95.2% |
| Revenue growth (YoY) | +0.5% | +34.9% |
| Gross margin | 12.7% | 57.3% |
| Net margin | −448.8% | −106.4% |
| P/E (TTM) | — | — |
| Price / sales | 0.4× | 0.1× |
| Net cash | -$12.6M | -$6.5M |
| Dividend yield | — | — |
| Volatility (60d) | 887.8% | 107.7% |
| Short % of float | 0.5% | 10.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).